| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1016/S0025-7753(10)70035-X |
| P8608 | Fatcat ID | release_couyhgfsangkxizsgjrfkijeo4 |
| P698 | PubMed publication ID | 21477699 |
| P2093 | author name string | Emilia Cercenado | |
| P2860 | cites work | The changing pattern of infection in neutropenic patients | Q47750416 |
| Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. | Q55067143 | ||
| Trends in antimicrobial resistance in 3469 enterococci isolated from blood (EARSS experience 2001-06, Spain): increasing ampicillin resistance in Enterococcus faecium | Q80005284 | ||
| Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-susceptible clinical methicillin-resistant S. aureus (MRSA) blood isolates from 2001-05 | Q80595494 | ||
| EXTRACTION OF A HIGHLY POTENT PENICILLIN INACTIVATOR FROM PENICILLIN RESISTANT STAPHYLOCOCCI | Q81079459 | ||
| [Study of the first outbreak of vanA enterococcus faecium in the Canary Islands] | Q84025835 | ||
| Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic | Q24614464 | ||
| The life and times of the Enterococcus | Q24616875 | ||
| Staphylococcus aureus infections | Q28131787 | ||
| Resistance to linezolid is mediated by the cfr gene in the first report of an outbreak of linezolid-resistant Staphylococcus aureus | Q28272797 | ||
| Laboratory, clinical, and epidemiological aspects of coagulase-negative staphylococci | Q30450189 | ||
| Antimicrobial resistance trends and outbreak frequency in United States hospitals | Q33196006 | ||
| Treatment failure resulting from resistance of Staphylococcus aureus to daptomycin | Q33233009 | ||
| Response to emerging infection leading to outbreak of linezolid-resistant enterococci | Q33884094 | ||
| Emergence of resistance among USA300 methicillin-resistant Staphylococcus aureus isolates causing invasive disease in the United States | Q34108596 | ||
| Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia | Q34783668 | ||
| Antimicrobial resistance to linezolid | Q35912430 | ||
| Impact of reduced vancomycin susceptibility on the therapeutic outcome of MRSA bloodstream infections. | Q36287998 | ||
| Update on clinical significance of coagulase-negative staphylococci | Q36640978 | ||
| Perspectives on Daptomycin resistance, with emphasis on resistance in Staphylococcus aureus | Q36903680 | ||
| Inhibitory and bactericidal activities of daptomycin, vancomycin, and teicoplanin against methicillin-resistant Staphylococcus aureus isolates collected from 1985 to 2007. | Q37190789 | ||
| Methicillin-resistant staphylococci 1965-75 | Q39347193 | ||
| Evaluation of endocarditis caused by methicillin-susceptible Staphylococcus aureus developing nonsusceptibility to daptomycin | Q41789314 | ||
| Nine-hospital study comparing broth microdilution and Etest method results for vancomycin and daptomycin against methicillin-resistant Staphylococcus aureus | Q41873909 | ||
| Development of daptomycin nonsusceptibility with heterogeneous vancomycin-intermediate resistance and oxacillin susceptibility in methicillin-resistant Staphylococcus aureus during high-dose daptomycin treatment | Q42430232 | ||
| First report of Staphylococcal clinical isolates in Mexico with linezolid resistance caused by cfr: evidence of in vivo cfr mobilization | Q42575330 | ||
| Emergence of daptomycin resistance in Enterococcus faecium during daptomycin therapy | Q42708842 | ||
| Multicity outbreak of linezolid-resistant Staphylococcus epidermidis associated with clonal spread of a cfr-containing strain. | Q42931166 | ||
| Methicillin resistant Staphylococcus aureus colonization in pigs and pig farmers | Q43223509 | ||
| Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin | Q45199316 | ||
| [Comparative activity of daptomycin against clinical isolates of methicillin-resistant Staphylococcus aureus and coagulase-negative staphylococci]. | Q46030066 | ||
| Methicillin-resistant Staphylococcus aureus: introduction and spread within a hospital | Q46085425 | ||
| Comparison of method-specific vancomycin minimum inhibitory concentration values and their predictability for treatment outcome of meticillin-resistant Staphylococcus aureus (MRSA) infections | Q46431265 | ||
| Daptomycin-resistant, methicillin-resistant Staphylococcus aureus bacteremia. | Q46433642 | ||
| Staphylococcus spp. in Spain: present situation and evolution of antimicrobial resistance (1986-2006) | Q46596272 | ||
| Vancomycin-resistant Staphylococcus aureus in the United States, 2002-2006. | Q46766488 | ||
| Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia | Q46826194 | ||
| Trends in antimicrobial resistance in health care-associated pathogens and effect on treatment | Q46851716 | ||
| P407 | language of work or name | Spanish | Q1321 |
| P921 | main subject | gram-positive bacteria | Q857288 |
| P304 | page(s) | 10-15 | |
| P577 | publication date | 2010-12-01 | |
| P1433 | published in | Medicina clínica | Q26854009 |
| P1476 | title | Update of antimicrobial resistance in Gram-positive microorganisms | |
| P478 | volume | 135 Suppl 3 |
| Q35715381 | Ceftaroline in complicated skin and skin-structure infections |
| Q33641712 | Molecular epidemiology of coagulase-negative Staphylococcus carriage in neonates admitted to an intensive care unit in Brazil. |
| Q84028196 | [Daptomycin in the context of antimicrobial resistance in Gram-positive bacteria] |
| Q84028199 | [Daptomycin therapy in patients with bacteremia] |
| Q83392400 | [Enterococcus: phenotype and genotype resistance and epidemiology in Spain] |
Search more.